Skip to main content

Toxicity Reduced With MRI-Guided Radiotherapy for Prostate Cancer

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 24, 2023 -- For patients with prostate cancer, magnetic resonance‐guided daily adaptive stereotactic body radiotherapy (MRg-A-SBRT) is associated with reduced toxicity compared with computed tomography‐guided nonadaptive prostate SBRT (CT-SBRT), according to a systematic review and meta‐analysis published online July 24 in Cancer.

Jonathan E. Leeman, M.D., from the Dana‐Farber Cancer Institute/Brigham and Women's Hospital in Boston, and colleagues conducted a meta-analysis to compare acute toxicity rates associated with MRg‐A‐SBRT and CT‐SBRT for prostate cancer. A total of 29 prospective studies, with 2,547 patients, met the inclusion criteria.

The researchers found that the pooled estimates for acute grade 2 or higher (G2+) genitourinary and gastrointestinal toxicity were 16 and 4 percent, respectively, for MRg-A-SBRT, compared with 28 and 9 percent, respectively, for CT-SBRT. The odds ratios for acute G2+ genitourinary and gastrointestinal toxicities comparing MRg-A-SBRT and CT-SBRT were 0.56 and 0.40, respectively, on meta-regression.

"Because there are multiple technical differences between these approaches, further prospective investigation is needed to pinpoint the specific underlying causes, and in particular the role of daily adaptive planning," the authors write. "Whether late toxicity and cancer control rates differ with the use of MRg‐A‐SBRT compared to CT‐SBRT will require longer follow‐up to determine."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

Planetary Health Diet Index Linked to Lower Total, Cause-Specific Mortality

MONDAY, June 10, 2024 -- A higher Planetary Health Diet Index (PHDI) is associated with a lower risk for total and cause-specific mortality, according to a study published online...

Prevalence of Iron Deficiency Varies With Different Definitions

MONDAY, June 10, 2024 -- The prevalence of iron deficiency varies significantly with three different definitions, according to a study published online June 7 in JAMA Network...

AI Blood-Based Lung Cancer Screening Test Developed for Fragmentome

MONDAY, June 10, 2024 -- A novel blood-based lung cancer screening test has been developed and validated using genome-wide sequencing to analyze cell-free DNA (cfDNA)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.